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Purpose: Corneal myofibroblasts differentiated from activated corneal stromal cells are the major cellular sources of
extracellular matrix synthesis for the repair of corneal injury. In this study, the effects of histone deacetylase  (HDAC)
inhibitors on the activation, proliferation, migration and senescence of corneal stromal cells were evaluated.
Methods: Primary human and mouse corneal stromal cells were harvested by sequential digestion with dispase and
collagenase,  and  cultured  in  DMEM/F-12  media  under  serum-free  (keratocytes),  serum-  (corneal  fibroblasts)  and
TGFβ1-supplemented   (corneal   myofibroblasts)   conditions.   The   responses   of   corneal   stromal  cells   to  HDAC
inhibitors  were  characterized  by  cDNA  microarray,  real  time  PCR,  immunocytochemistry,  and  western  blot
analysis. The effects of HDAC inhibitors on corneal fibroblast proliferation, cell cycle distribution, migration and
senescence were also assessed in vitro.
Results: Fetal bovine serum and TGFβ1 activated the transdifferentiation of corneal stromal cells into fibroblasts and
myofibroblasts, indicated by cell spreading, renewed assembly of actin filaments and enhanced expression of extracellular
matrix components, all of which were suppressed by the addition of HDAC inhibitors. HDAC inhibitors inhibited the
proliferation of corneal fibroblasts by decreasing the proportion in the S-phase and increasing the proportion in the G0/
G1 and G2/M cell cycle checkpoints. HDAC inhibitors showed a dose-dependent inhibitory effects on the migration of
corneal fibroblasts. In addition, HDAC inhibitors induced the senescence of corneal myofibroblasts as shown by enhanced
staining of β-galactosidase and upregulated expression of p16ink4a.
Conclusions:  HDAC  inhibitors  may  affect  corneal  stromal  cells  by  inhibiting  myofibroblastic differentiation, cell
proliferation, migration and by inducing cell senescence. Thus, this has implications for future studies in the development
of promising drugs in the prevention or treatment of corneal haze and scar formation.
Corneal keratocytes are the major cellular components in
the corneal stroma. Normally, the cells remain quiescent and
synthesize  key  extracellular  matrix  (ECM)  components,
maintaining their turnover in corneal stroma. During corneal
wound healing, except for the anterior keratocytes undergo
apoptosis, the corneal stromal cells in the posterior stroma are
activated  and  undergo  the  transformation  into  corneal
fibroblasts and myofibroblasts after migration to the wound
site, which were characterized by the expression of α-smooth
muscle actin (α-SMA), the synthesis of large amounts of ECM
components, and the increased proliferation and acquisition
of contractile properties [1]. Recent studies have shown that
TGFβ1 increased corneal stromal cell proliferation and was
the only isoform of TGFβs to promote the transdifferentiation.
From a therapeutic point of view, molecules that can block the
fibrogenic effects of TGFβ1, collagen synthesis, fibroblast
proliferation are of great clinical interests [2]. In mammalian
cells,  the  state  of  acetylation  or  deacetylation  of  core
nucleosomal histones is regulated by the interactions between
histone acetyltransferases (HATs) and histone deacetylases
(HDACs), which play important roles in the regulation of gene
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expression by affecting chromatin structure [3]. Currently,
known  inhibitors  of  histone  deacetylases,  such  as  sodium
butyrate  (NaBu),  trichostatin  A  (TSA)  and  valproic  acid
(VPA),  can  induce  the  hyperacetylation  of  histones  and
nonhistone protein substrates, such as NF-kappaB, HIF-1α,
etc [3,4]. As reported in recent studies, HDAC inhibitors exert
antifibrotic  effects  by  suppressing  the  main  features  of
TGFβ-induced  myofibroblastic  differentiation  of  cultured
hepatic stellate cells [5], pancreatic stellate cells [6,7] and skin
fibroblasts [8,9]. In vivo studies revealed that TSA prevented
the dermal accumulation of extracellular matrix in bleomycin-
induced fibrosis [10]. Corneal stromal cells shared similar
roles and characteristics with hepatic stellate cells and skin
fibroblasts  [1,11-14],  so  we  hypothesized  that  epigenetic
regulations may be involved in the differentiation of corneal
keratocytes  into  fibroblasts  and  myofibroblasts.  Recently,
Horswill reported that DNA methylation was involved in the
regulation  of  maspin  expression  in  the  conversion  of
keratocytes to fibroblasts [15]. However, the effects of HDAC
inhibitors  on  the  activation  and  differentiation  of  corneal
stromal cells remain elusive.In the present study, we found
that  the  inhibitors  of  histone  deacetylases  inhibited  the
activation and transdifferentiation of corneal stromal cells,
suppressed  the  proliferation  of  corneal  fibroblasts  by
decreasing the proportion of cells in S-phase, and inhibited
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2556the  migration  of  corneal  fibroblasts  in  a  dose-dependent
manner. In addition, HDAC inhibitors induced the senescence
of corneal fibroblasts as shown by the enhanced staining of
β-galactosidase and the upregulated expression of P16INK4A.
The above results demonstrated that epigenetic modifications
may play important roles in the different phases of corneal
wound  healing.  Further  investigations  into  the  molecular
mechanisms may reveal new therapeutic strategies for the
prevention or treatment of corneal haze and scar formation.
METHODS
Isolation of human and murine corneal stromal cells: For the
isolation  of  human  corneal  stromal  cells,  human  corneal
tissues were obtained from the Eye Bank at Shandong Eye
Institute after the central corneal buttons were removed for
clinical  application.  Corneal  epithelium  and  endothelium
were removed by digestion with 50 mg/ml dispase II (Roche)
overnight at 4 °C. The corneal stroma was cut into pieces and
incubated 6–8 h at 37 °C in DMEM/F-12 medium containing
1.25 mg/ml collagenase (Invitrogen), until the tissue smeared
onto  the  dish  bottom  [16,17].  For  the  isolation  of  mouse
corneal stromal cells, mice (C57BL/6) eyes were enucleated
with forceps after euthanasia, and corneal stromal cells were
isolated as described above. The acquired human and mouse
keratocytes  were  suspended  in  DMEM/F-12  medium
supplemented with 20 mM HEPES, ITS (5 μg/ml insulin,
5 μg/ml transferrin, and 5 ng/ml sodium selenite), 100 U/ml
penicillin,  and  100  mg/ml  streptomycin  to  maintain  their
quiescent status [18,19].
Cell culture and treatment: Freshly isolated corneal stromal
cells were divided into 5 groups as followed, The 1st group
cells were plated as primary quiescent keratocytes on cell
culture dishes in DMEM/F-12 medium containing HEPES,
ITS and antibiotics as described above. The 2nd group cells
were cultured in the DMEM/F-12 medium containing 10%
fetal bovine serum (FBS, Gibco) for the activation of corneal
fibroblasts. The 3rd group cells were treated with 1ng/ml
TGFβ1 (R&D) for 3 to 5 days in the presence of 10% FBS
[11,17]  for  the  myofibroblastic  transdifferentiation.  To
examine the effects of HDAC inhibitors (NaBu and TSA) on
the activation and transdifferentiation of corneal stromal cells,
the 4th and 5th group cells were treated with FBS or TGFβ1
in the presence of HDAC inhibitors. The responses of corneal
stromal  cells  to  HDAC  inhibitors  were  characterized  by
cDNA microarrays, real time PCR, immunocytochemistry
and  western  blot  analysis.  Cell  proliferation,  cell  cycle
distribution and migration were determined by CFSE or PI
staining  and  FACS  analysis  and  wound  healing  assay  as
described below.
cDNA microarray: The 3rd passage corneal fibroblasts were
divided  into  three  groups  as  follows:  untreated  corneal
fibroblasts  were  considered  as  the  control  group,  corneal
fibroblasts treated with TGFβ1 for four days in the presence
of  10%  FBS  were  considered  as  the  myofibroblastic
differentiation  group,  and  corneal  fibroblasts  treated  with
TGFβ1 and 400 nM TSA for four days were considered as the
myofibroblastic  differentiation  inhibition  group.  All  three
populations  of  corneal  fibroblasts  were  used  for  cDNA
microarrays as described previously [20]. In brief, total RNAs
were extracted using Trizol (Invitrogen, Gaithersburg, MD),
precipitated  with  isopropanol,  and  purified  using  the
NucleoSpin  RNA  clean-up  Kit  (MACHEREY-NAGEL,
Germany). The quality and quantity of total RNA samples
were  determined  by  formaldehyde-denatured  agarose  gel
electrophoresis and spectrophotometry, respectively.
For the cDNA microarray, RNA was reverse-transcribed
to  cDNA  and,  during  this  process,  a  T7  sequence  was
introduced into the cDNA. The T7 RNA polymerase-driven
RNA synthesis was used for the preparation and labeling of
cRNA with Cy3-dCTP and Cy5-dCTP. The labeled products
were purified with the PCR NucleoSpin Extract II Kit. An
equal amount of Cy3 and Cy5 labeled probes were mixed and
used  for  hybridization  to  one  35k  human  genome  array
(CapitalBio Corp., Beijing, China), following the protocol
provided by the manufacturer. The hybridization signals were
acquired  by  using  the  LuxScan  10KA  microarray  laser
scanner (CapitalBio) and analyzed using the LuxScan™ 3.0
Software. Specifically, the Linear & Lowess method and the
rank consistency filter were used for normalization of the
features. The rank consistency filter selects features that fall
within the central tendency of the data by observing consistent
trends between the red and green channels. To be counted as
a valid feature, the feature has to pass four criteria: 1) they are
positive and significantly different compared with just the
background, 2) the signals are uniform in the spot, 3) the
signals  are  not  saturated,  and  4)  they  are  not  population
outliers in either channel. If the features failed in any one of
the four criteria, they were flagged and excluded from further
analysis.
Real  time  polymerase  chain  reaction:  Total  RNAs  were
extracted  from  corneal  fibroblasts,  TGFβ1-treated  corneal
fibroblasts and TGFβ1 and TSA co-treated corneal fibroblasts
using NucleospinRNA Kits (BD Biosciences, Palo Alto, CA).
cDNAs were synthesized from total RNA using an AMV first-
strand cDNA synthesis kit (BBI, Toronto, Canada), according
to the manufacturer’s instructions. Quantitative real time PCR
was  performed  using  Taqman  reagents  and  the  Applied
Biosystems  7500  Real  Time  PCR  System  (Applied
Biosystems, Foster City, CA) according to the instructions of
the manufacturer. The specific primers and probes used in this
assay are listed in Table 1. Cycling conditions were 10 min at
95 °C followed by 40 two-step cycles (15 s at 95 °C and 1 min
at 60 °C). The quantification data were analyzed with the SDS
System Software (Applied Biosystems) using GAPDH as an
internal control.
Immunocytochemistry  and  western  blot  analysis:  For
immunocytochemistry,  cells  were  fixed  with  4%
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After blocking with 5% normal goat serum, the samples were
incubated with FITC-conjugated phalloidin (Alexis), or with
primary rabbit anti-α-SMA and anti-collagen I, overnight at
4  °C.  Following  three  washes  with  PBS,  the  cells  were
incubated  with  FITC  or  rhodamine-conjugated  goat  anti-
rabbit secondary antibodies and counterstained with DAPI.
Cell staining was examined under a Nikon confocal laser-
scanning  microscope.  Antigen-unrelated  primary  antibody
was used for negative control staining.
For western blot analysis, total proteins were extracted
using  Active  Motif  nuclear  and  cytoplasm  extract  kit,
according  to  manufacturer’s  instructions.  Briefly,  the
collected cells were lysed in the hypotonic buffer containing
detergent  and  centrifuged  for  30  s  at  14,000x  g.  The
supernatants were collected and stored at −80 °C, until ready
for use. Samples were run on 10% SDS–PAGE gels for 1 h at
160 V and then transferred to nitrocellulose. The blots were
blocked in 5% non-fat dry milk dissolved in TBST for at least
1 h, then incubated with rabbit anti α-SMA and anti collagen
I in TBST for 1 h at room temperature. The blots were washed
three times, each time with 10 ml of TBST, and then incubated
for 1 h at room temperature with a horseradish peroxidase-
conjugated  secondary  antibody  (Amersham  Biosciences).
Finally, the blots were washed three times, each time with
10  ml  of  TBST,  and  were  visualized  via  enzyme-linked
chemiluminescence using the ECL kit (Chemicon).
Cell proliferation analysis: CFSE staining was performed as
previously described, to evaluate the proliferation of corneal
fibroblasts after the treatment with NaBu or TSA [21]. Briefly,
corneal fibroblasts were washed with PBS for 3 times and
resuspended in pre-warmed PBS containing 2 µM CFSE dye
(CFDA SEM Cell Tracer kit; Molecular Probes) for 15 min at
37 °C. Cells were then washed and incubated with fresh PBS
for an additional 30 min to allow complete modification of the
probe before adoptive cell transfer. As described above, the
labeled cells were cultured in the presence or absence of
HDAC inhibitors for 3 days and analyzed by flow cytometry.
Cell  cycle  analysis:  Flow  cytometry  was  performed  to
measure the cell cycle distribution of HDAC inhibitors treated
corneal fibroblasts [22]. For the staining of cellular DNA, the
cells were fixed in ice-cold 70% ethanol and incubated in PBS
containing 30 μg/ml propidium iodide (PI) and 0.3 mg/ml
RNase  A.  The  measurements  were  made  with  a  Becton
Dickinson FACS Calibur machine, adapted for excitation with
a 488 nm argon laser, and 582/42 nm band-pass filter for
detecting PI emission. A total of 20,000 cells were collected
by  FACS  and  analyzed  using  the  CellQuest  3.1  software
(Becton Dickinson). On each occasion, at least three samples
of each treatment were analyzed.
Cell migration analysis: Corneal fibroblast migration was
evaluated  by  wound  healing  assay  according  to  previous
descriptions [23]. Briefly, corneal fibroblasts were seeded on
24 well tissue culture plates. When the cells reached 90%
confluence, they were wounded with a micropipette tip and
marked as the injury lines. The cultures were rinced with
culture medium to remove detached cells, and incubated with
growth medium containing different concentrations of TSA
or solvent control for 24 h. Digital images of wound closure
were  obtained  and  used  for  quantitative  assessment  of
migration  by  counting  the  number  of  cells  that  migrated
beyond  the  injury  lines  in  five  views.  Each  assay  was
conducted at least triplicate.
Senescence-associated β-galactosidase staining assay: Cell
senescence was examined with the senescence-associated β-
galactosidase  (SA-β-gal)  staining  Kit  (Beyotime,  Haimen,
China), according to the manufacturer’s instructions. Briefly,
the cells were washed twice with PBS and fixed for 15 min in
room temperature, then washed again to remove the fixing
solution,  incubated  in  the  SA-β-gal  staining  solution  for
overnight at 37 °C and viewed under the Nikon microscope.
The different staining densities were separately calculated by
computerized image analysis, using imagepro plus software
(Media Cybernetics, Silver Spring, MD). The cells of positive
control group were incubated daily in the presence of 100µM
H2O2 for 1 h for 3 days. The cells were washed with PBS and
incubated in the normal culture medium for 24 h. After the
last treatment, the cells were allowed to recover for 3 days
before the SA-β-gal staining.
Statistical analysis: The data are presented as means±SD. The
differences between control and experimental conditions were
tested with Student’s t-tests. A p value of less than 0.05 was
considered to be statistically significant.
RESULTS
HDAC  inhibitors  suppressed  TGFβ1  mediated
myofibroblastic differentiation: Human and mouse corneal
TABLE 1. PRIMERS USED FOR REAL TIME PCR.
Gene Forward primer Reverse primer Probe
Product
(bp)
α-SMA GGTGACGAAGCACAGAGCAA CAGTTGGTGATGATGCCATGTT AGAGGAATCCTGACCCTGAAGTACCCGA 74
Collagen I TTGTGCGATGACGTGATCTGT TTGGTCGGTGGGTGACTCTG CGAGGGCGAGTGCTGTCCCGT 111
Collagen IV GCAAACGCTTACAGCTTTTGG GGACGGCGTAGGCTTCTTG CGCCACCATAGAGAGGAGCGAGATG 69
p21 waf1/cip1 CAGACCAGCATGACAGATTTC TTAGGGCTTCCTCTTGGAGA ACCACTCCAAACGCCGGCTG 66
p27 kip1 CCTCCTCCAAGACAAACAGC CATTCAGAGCGGGATTATCTTT TCGAGTTCCTGACAAGCCACGC 89
p16 ink4a AAGGTCCCTCAGACATCCC TGTAGGACCTTCGGTGACTG TCCGGAGGTTTCTCAGAGCCTCTC 90
GAPDH ATGCTGGCGCTGAGTACGT AGCCCCAGCCTTCTCCAT TGGAGTCCACTGGCGTCTTCA 65
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2558stromal cells were exposed to TGFβ1 and/or HDAC inhibitors
for  3–5  days  to  examine  the  potential  effects  of  HDAC
inhibitors on the differentiation of TGFβ1-induced corneal
keratocytes into myofibroblasts. Morphological changes were
assessed and the relative amounts of α-SMA and collagens
transcript and protein levels were evaluated by real time PCR,
western blot and immunocytochemistry, respectively.
Morphological  analysis:  In  normal  corneal  stroma,  the
keratocytes  showed  stellate  morphology  with  numerous
cytoplasmic  extensions.  Similar  to  their  assumed  in  vivo
morphology,  freshly  isolated  mouse  corneal  keratocytes
exhibited dendritic morphology when cultured in the serum-
free medium (Figure 1A). Serum and TGFβ induced rapid
changes of cellular morphologies from dendritic to spreading,
and finally to myofibroblastic morphology (Figure 1B,C).
However, both the FBS- and TGFβ-induced morphological
changes of mouse corneal keratocytes were suppressed by
TSA (Figure 1D-F), which preserved the dendritic shapes and
long cytoplasmic extensions. The inhibitions of TSA on the
Figure  1.  Trichostatin  A  prevented  morphological  changes  of
TGFβ-mediated  myofibroblastic  differentiation  of  corneal
fibroblasts. Freshly isolated mouse corneal keratocytes exhibited a
dendritic-like morphology when cultured in the serum-free medium
(A). Serum (10% FBS) and TGFβ (1 ng/ml) induced rapid changes
of cellular morphologies from dendritic to spreading and caused cells
to finally assume myofibroblastic morphology (B, C). The addition
of  TSA  suppressed  the  differentiation  mediated  by  fetal  bovine
serum (D) and TGFβ (E, F), and the inhibition was dose-dependent
as shown in (E; 100 nM TSA) and (F; 400 nM). Human quiescent
corneal  keratocytes  (G),  TGFβ  induced  the  differentiated
myofibroblasts (H), and 400 nM TSA treated corneal fibroblasts (I)
exhibited similar morphological changes. (200X)
morphologic changes occurred in a dose-dependent manner,
as shown in Figure 1E (100 nM TSA) and Figure 1F (400 nM).
For the human keratocytes, 400 nM TSA also inhibited the
myofibroblastic transdifferentiation of corneal stromal cells
induced by TGFβ in the presence of 10% FBS (Figure 1G-I).
Immunocytochemistry  analysis:  Immunocytochemistry
analysis  was  used  to  confirm  the  myofibroblastic
differentiation  of  mouse  corneal  stromal  cells  induced  by
TGFβ1.  As  shown  in  Figure  2A,  TGFβ1-treated  cells
exhibited spreading morphology and enhanced staining with
FITC-conjugated phalloidin, which showed the organization
of  F-actin  into  prominent  intracellular  bundles  that  was
consistent with the formation of stress fibers. Staining with
antibodies to α-SMA and collagen I also revealed an enhanced
expression of corneal fibroblasts induced by 1ng/ml TGFβ1
for four days. However, when the freshly isolated mouse
keratocytes were treated with TGFβ1 in the presence of 400
nM  TSA,  the  cells  retained  their  small  dendritic-like
morphology and weak staining of phalloidin (Figure 2D).
Although  the  staining  of  collagen  I  antibody  was  weakly
positive for the corneal stromal cells treated with TGFβ1 and
TSA, the cells showed no staining or only minimal staining
with antibodies for α-SMA that is specific to differentiated
myofibroblasts. In addition, 5 mM NaBu exhibited similar
inhibitory effects as 400 nM TSA (data not shown). Therefore,
HDAC  inhibitors  were  able  to  prevent  TGFβ1-mediated
myofibroblastic  differentiation  of  corneal  stromal  cells  in
vitro as assessed by morphological and immunocytochemistry
analyses.
Gene expression analysis: The results of microarrays revealed
that the expressions of genes associated with myofibroblastic
Figure  2.  Trichostatin  A  suppressed  the  myofibroblastic
differentiation of mouse corneal stromal cells induced by TGFβ1.
Corneal  fibroblasts  treated  with  1  ng/ml  TGFβ1  for  4–5  days
exhibited enhanced staining with FITC-conjugated phalloidin (A),
α-SMA (B), and collagen I (C). However, the keratocytes treated
with TGFβ1 in the presence of 400 nM TSA remained small with
dendritic-like morphology and weak or only minimal staining of
phalloidin (D), α-SMA (E), and collagen I (F). Bar, 50 µm.
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2559differentiation  of  corneal  fibroblasts  were  upregulated
markedly after the induction with TGFβ1 for 4 days, mainly
for the collagen family, such as collagen I, IV, VII, X, XI, and
several members of the actin family, such as α-SMA, γ-enteric
smooth muscle actin, α-cardiac actin and α-actinin 1 (Table
2). The addition of 400 nM TSA significantly suppressed the
upregulation  of  the  expressions  of  the  genes  induced  by
TGFβ  (Table  2).  The  partial  results  of  the  microarrays,
including collagen I and IV, α-SMA were further confirmed
by real time PCR analysis. Compared with control conditions,
the  stimulation  of  human  corneal  fibroblasts  with  TGFβ1
induced 3.92, 6.34 and 3.35 fold increases in the abundance
of collagen I, collagen IV and α-SMA, respectively. TSA at
400  nM  concentration  down-regulated  the  expressions  of
collagen I (0.48-fold), collagen IV (0.52-fold) and α-SMA
(0.41-fold)  compared  with  TGFβ  treated  cells  (Figure  3),
which  were  consistent  with  the  results  of  the  microarray
analysis.
Western blotting analysis: For the quantification of protein
levels, the effects of TGFβ1 and HDAC inhibitors on the
expression of α-SMA and collagen I protein were evaluated
by  western  blotting.  The  results  are  shown  in  Figure  4.
TGFβ1 significantly upregulated the protein levels of α-SMA
and collagen I by 1.8 and 2.2 fold, respectively, while 400 nM
TSA strongly inhibited the synthesis of α-SMA and collagen
I  by  32%  and  57%,  respectively,  and  5  mM  NaBu  also
suppressed the synthesis of α-SMA and collagen I by 43% and
69%, respectively. The cells treated with HDAC inhibitors
alone showed similar expression patterns to the control group
(data  not  shown).  In  conclusion,  TGFβ1  upregulated  the
expressions of fibrosis-associated factors, and thus promoted
the  transdifferentiation  of  corneal  fibroblasts  into
myofibroblasts. TSA and NaBu almost completely inhibited
the expressions of fibrosis-related genes, both at the mRNA
and protein levels.
HDAC  inhibitors  inhibited  the  proliferation  of  corneal
fibroblasts: Carboxy-fluorescein diacetate, succinimidyl ester
(CFSE) is a membrane permeable dye used to examine the
proliferation of specific lymphocyte subsets [21,22]. During
each round of cell division, relative fluorescence intensity of
the  dye  is  decreased  by  half.  Here,  we  used  it  for  the
examination of the inhibitory effects of HDAC inhibitors on
the proliferation of corneal fibroblasts. Mouse and human
corneal fibroblasts were first incubated with CFSE, which
passively diffused into cells. Excess dye was washed away
and the cells are treated with TSA or NaBu for three days.
Corneal fibroblasts showed heterogeneous intensity in the
fluorescence,  which  showed  different  successive  cell
generations (data not shown). The results of FACS analysis
showed that both of the two HDAC inhibitors inhibited the
proliferation of human (Figure 5A) and mouse (Figure 5B)
corneal fibroblasts.
HDAC  inhibitors  caused  cell  cycle  arrested  of  corneal
fibroblasts: The results of CFSE staining and FACS analysis
revealed that HDAC inhibitors inhibited the proliferation of
corneal  fibroblasts.  As  described  previously,  inhibitory
Figure 3. Real time PCR confirmation of the microarray results.
Compared with control conditions, stimulation of human corneal
fibroblasts with TGFβ1 induced 3.92, 6.34, and 3.35 fold increases
in the abundance of collagen I, collagen IV and α-SMA, respectively.
Compared with TGFβ treated cells, TSA and TGFβ treatment down-
regulated the expressions of collagen I (0.48 fold), collagen IV (0.52
fold) and α-SMA (0.41 fold).
TABLE 2. TSA INHIBITED THE NORMALLY UPREGULATED EXPRESSION OF FIBROTIC-RELATED GENES INDUCED BY TGFΒ.
TGFβ/
control
TGFβ+ TSA/
TGFβ Description RefSeq
3.8358 0.3852 Collagen alpha 1(I) chain precursor NM_152624
8.8109 0.4127 Collagen alpha 1(IV) chain precursor NM_032812
3.8324 0.6006 Collagen alpha 1(VII) chain precursor NM_013390
7.1472 0.0319 Collagen alpha 1(X) chain precursor NM_003725
6.3617 0.7244 Collagen alpha 1(XI) chain precursor NM_001718
5.8157 0.1892 Actin, aortic smooth muscle NM_014840
3.4333 0.3078 Actin, gamma-enteric smooth muscle NM_138431
3.1596 0.5266 Actin, alpha cardiac NM_001937
2.6436 0.4768 Alpha-actinin 1 NM_000219
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2560effects  of  HDAC  inhibitors  on  the  proliferation  are  often
caused by cell cycle arrested [3]. Here, we evaluated the effect
of TSA and NaBu on the cell cycle profiles of human corneal
fibroblasts. As shown in Figure 6, about 64.4% and 6.5% of
normal human corneal fibroblasts were in the G0/G1 and G2/
M phases, respectively, and 29.1% of the cells were in the S
phase. In contrast, after the treatment with 400 nM TSA or
5 mM NaBu for three days, the proportion of cells in the G0/
G1  phase  were  80.9%  (TSA)  and  78.5%  (NaBu),  the
proportion of cells in the G2/M phase were 10.4% (TSA) and
9.4% (NaBu), and the proportion of cells in the S phase was
reduced to 8.7% (TSA) and 12.1% (NaBu). Taken together,
these  data  suggested  that  TSA  and  NaBu  reduced  the
proliferation of corneal fibroblasts, and this was caused by
decreasing the proportion of cells in S phase and increasing
the  proportion  of  cells  in  the  G0/G1  and  G2/M  cell  cycle
checkpoints (Figure 6).
HDAC  inhibitors  repressed  the  migration  of  corneal
fibroblasts:  The  migration  of  corneal  fibroblasts  plays  an
important role in the scar formation [1]. Here we evaluated
the inhibitory effects of TSA on the migration of corneal
fibroblasts using the wound healing assay. The number of
Figure  4.  TSA  and  NaBu  suppressed  the  TGFβ-mediated
upregulation in the expression of collagen I and α-SMA at the protein
levels.  As  shown  by  the  analysis  (B)  of  western  blotting  (A),
TGFβ1 significantly upregulated the protein levels of α-SMA and
collagen I by 1.8 and 2.2 fold, respectively, while 400 nM TSA
strongly inhibited the synthesis of α-SMA and collagen I by 32% and
57%, respectively, and 5 mM NaBu suppressed the synthesis of α-
SMA and collagen I by 43% and 69%, respectively.
cells  migrated  into  the  two  injury  lines  were  compared
between HDAC inhibitor-treated cells and untreated cells. As
shown in Figure 7, cell migration was inhibited in a dose-
dependent manner by different concentrations of TSA, with
up  to  78.64%  and  69.98%  at  200  nM  and  400  nM  TSA
incubation,  respectively.  Sodium  butyrate  showed  similar
inhibitory effects of migration on corneal fibroblasts (data not
shown).
HDAC inhibitors induced the senescence-like state of corneal
myofibroblasts: Senescent cells can accumulate senescence-
associated  β-galactosidase  activity  that  distinguishes  them
from quiescent cells [24]. We found that TSA induced corneal
myofibroblasts showed reduced saturation densities and more
prominent β-galactosidase activity than the control cells of
equal density (Figure 8). Furthermore, the results of real time
PCR for p16ink4a, p27kip1 and p21cip1/waf1, the cell cycle-related
transcriptional  factors  and  biochemical  markers  of  cell
senescence [3], revealed that treatment with TSA promoted
their expressions in human corneal fibroblasts by 35.98, 6.98
and 5.15 fold, respectively, compared with the untreated cells
Figure  5.  TSA  and  NaBu  inhibited  the  proliferation  of  corneal
fibroblasts. Human (A) or mouse (B) corneal fibroblasts were treated
with 400 nM TSA or 5 mM NaBu for 3 days. In vitro proliferation
assays were performed with the fluorescent dye CFSE and analyzed
by FACS. Loss of CFSE fluorescence reflects cellular division.
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2561(Figure  9).  Taken  together,  the  results  demonstrated  that
HDAC inhibitors also induced the senescence-like state of
corneal  myofibroblasts,  except  for  the  inhibition  of
myofibroblastic  differentiation  and  cell  proliferation  and
migration.
DISCUSSION
Mounting data confirms that activated corneal stromal cells
play an important role in corneal wound healing [1]. The
formation of fibrotic stromal scars has often been described
after  refractive  surgery  or  severe  ocular  injury,  which  is
characterized by the increasing density of corneal fibroblasts,
the  appearance  of  corneal  myofibroblasts  and  the
disorganized corneal stromal matrix [25,26]. In the present
study, we found that (1) HDAC inhibitors strongly inhibited
the activation and myofibroblastic differentiation of corneal
stromal cells, including morphological changes, expression of
collagens and α-SMA, and the distribution of stress fibers, (2)
HDAC  inhibitors  inhibited  the  proliferation  of  corneal
fibroblasts by decreasing the proportion of cells in S-phase
and increasing the proportion of cells in the G0/G1 and G2/M
cell cycle checkpoints, (3) HDAC inhibitors repressed the
migration of corneal fibroblasts in a dose-dependent manner,
and (4) HDAC inhibitors induced the senescence state of
corneal myofibroblasts (Figure 10).
HDAC inhibitors suppressed the morphological changes
of corneal stromal cells induced by serum and TGFβ as their
roles  in  hepatic  and  pancreatic  stellate  cells  and  skin
fibroblasts [5,7,8]. Specifically for the mouse cells, treatment
with HDAC inhibitors maintained the original morphology of
Figure 6. Cell cycle distribution of corneal fibroblasts treated with
TSA or NaBu. In normal human corneal fibroblasts, about 64.4%,
6.5% and 29.1% were in the G0/G1, G2/M, and S phase, respectively.
After treatment with 400 nM TSA or 5 mM NaBu for 3 days, the
proportion of cells in the G0/G1 phase increased to 80.9% with TSA
and to 78.5% with NaBu, the proportion of cells in the G2/M phase
increased  to  10.4%  with  TSA  and  9.4%  with  NaBu,  and  the
proportion of cells in the S phase reduced to 8.7% with TSA and
12.1% with NaBu.
corneal stromal cells in vivo. Along with the inhibitory effects
on morphological changes, TSA-treated cells down-regulated
the expressions of collagens and α-SMA mRNA and protein
to their basal levels. The mechanisms of inhibitory effects of
TSA on the myofibroblastic differentiation of corneal stromal
cells need to be further elucidated. Inhibitory effects of HDAC
inhibitors  on  cell  proliferation  and  migration  has  been
described in both normal and transformed cells [27,28]. Here,
we found that 400 nM TSA or 5 mM NaBu decreased the
proportion of cells in S-phase and increased the proportion of
cells  in  the  G0/G1  and  G2/M  cell  cycle  checkpoints.
Furthermore, the expression of p21waf1/cip1 and p27kip1, the two
cell  cycle  cyclin-dependent  kinase  (CDK)  inhibitors
associated  with  G0/G1  and  G2/M  cell  cycle  arrests,  were
upregulated after the treatment with TSA. Thus, we conclude
that  the  upregulated  expression  of  p21waf1/cip1  and  p27kip1
induced  by  HDAC  inhibitors  may,  at  least  partly,  be
Figure 7. Effects of TSA on wound healing migration of corneal
fibroblasts. The wounds were introduced by scraping the cell layers
with a pipette tip. A: Representative photographs of migrated cells
that received either control treatment or different concentrations of
TSA. B: The number of cells migrated between the injury lines were
counted and compared. Migration rate was determined as follows:
migration rate=(cell number of TSA group between the injury lines/
cell number of control group between the injury lines) x100%.
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arrest effects of corneal fibroblasts. For the evaluation of
migration inhibitory effects, wound healing assay were used.
Because of the fibroblastic properties, we counted the number
of cells migrated between the two injury lines instead of the
measurement of wound width. The results showed that TSA
inhibited  the  migration  of  corneal  fibroblasts  in  a  dose-
dependent  manner.  However,  the  difference  became
significant when the cells were treated with the concentration
of TSA above 100 nM.
In the analysis of real time PCR, we observed surprisely
that,  compared  with  the  untreated  human  corneal
myofibroblasts,  400  nM  TSA  increased  the  expression  of
p16ink4a by about 36-fold, which is a well known marker of cell
senescence  [29,30].  So  we  hypothesized  that  HDAC
inhibitors could induce the senescence-like state of corneal
myofibroblasts, except for the inhibition of myofibroblastic
differentiation and cell proliferation and migration. To further
confirm  this  hypothesis,  we  tested  the  activity  of  the
senescence  associated  β-galactosidase  (SA-β-Gal)  that
distinguishes the senescent cells from quiescent cells [31,32].
As  shown  by  the  staining  of  SA-β-Gal,  TSA-stimulated
human corneal myofibroblasts expressed enhanced levels of
Figure  8.  TSA  induced  the  senescence-like  state  of  corneal
fibroblasts as indicated by β-galactosidase staining. TSA at 400 nM
induced reduced saturation densities in corneal fibroblasts and more
prominent β-galactosidase activity (B) than the untreated cells of
equal  density  (A),  while  the  positive  control  cells  (treated  with
100µM H2O2) showed enhanced staining of β-galactosidase (C). D:
Image  quantitative  analysis  of  different  β-galactosidase  staining
densities; the number of asterisks represents different densities with
the three astrisks indicating the strongest staining of β-galactosidase.
SA-β-Gal  activity.  Furthermore,  from  the  results  of
microarray analysis, we observed that the expression of other
well  known  markers  of  replicative  senescence  was
upregulated, such as MMP1 by 3.52 fold, while IGFBP2,
IGFBP4 and IGFBP5 were upregulated by 8.12, 2.20, and
4.03  fold,  respectively.  However,  IGFBP3  was
downregulated by 0.39 fold by HDAC inhibitors in the cDNA
microarray analysis (data not shown), which was consistent
with previous reports that showed that the expressions of
Figure 9. TSA caused the upregulation of the expressions of cell
cycle-related transcriptional factors and biochemical markers of cell
senescence. Compared with the untreated cells, the expressions of
p16ink4a, p27kip1 and p21cip1/waf1 were upregulated by 35.85, 6.98, and
5.15 fold, respectively, by TSA.
Figure 10. Schematic diagram of multiple effects of HDAC inhibitors
on corneal stromal cells. HDAC inhibitors inhibited myofibroblastic
differentiation of corneal stromal cells, repressed cell proliferation
and migration of corneal fibroblasts, and induced cell senescence of
corneal myofibroblasts.
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the  IGFBP3  expression  declined  when  the  cells  were
completely senescent [29,33].
It  should  be  mentioned  that  the  inhibitory  effects  of
HDAC  inhibitors  may  be  partially  reversible  as  previous
descriptions  [34-36],  including  the  myofibroblastic
differentiation,  proliferation  and  migration,  and  the
senescence-inducing  effects  on  corneal  stromal  cells.  As
showed in Figure 11, the expression of collagen I and α-SMA
were upregulated after the removal of TSA of 4 days, and even
rescued  from  the  inhibition  of  HDAC  inhibitors  in  the
presence of TGFβ1. In conclusion, the inhibitory effects of
HDAC  inhibitors  on  myofibroblastic  differentiation  of
corneal  stromal  cells  could  be  reversed  by  the  persistent
existence of TGFβ, but the overall anti-fibrotic effects of
HDAC  inhibitors  on  corneal  scar  formation  should  be
evaluated in vivo.
In conclusion, we confirmed the inhibitory effects of
HDAC inhibitors on corneal stromal cells were regulated by
multiple  mechanisms,  including  the  inhibition  of
myofibroblastic differentiation of corneal stromal cells, the
suppression  of  proliferation  and  migration  of  corneal
fibroblasts and the induction of cell senescence of corneal
myofibroblasts.  Thus,  further  investigation  of  HDAC
inhibitors  may  provide  insights  for  developing  promising
drugs for the prevention or treatment of corneal haze and scar
formation.
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